Try our beta test site
36 studies found for:    " March 30, 2011":" April 29, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Completed Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Condition: HIV Infections
Interventions: Behavioral: Text messaging plus EMA;   Behavioral: Treatment as usual
2 Unknown  Improving Antiretroviral Medication Adherence Among HIV-infected Youth
Condition: HIV Infection
Intervention: Behavioral: Positive STEPS
3 Terminated
Has Results
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Condition: HIV Disease
Interventions: Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
4 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
5 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
6 Completed
Has Results
Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)
Condition: HIV Infections
Interventions: Biological: TUTI-16 (1.0 mg);   Other: Placebo
7 Completed Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
8 Completed
Has Results
Drug Drug Interaction of BI 201335 and Tenofovir
Condition: HIV Infections
Intervention: Drug: tenofovir/BI 201335
9 Unknown  Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
10 Completed Microparticles, Vector of Genetic Information During HIV Infection
Condition: HIV,
Intervention: Biological: Blood samples
11 Terminated Effects of IGF-I in HIV Metabolic Disease
Condition: HIV Lipodystrophy
Interventions: Drug: mecasermin;   Drug: Placebo control
12 Completed Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: empowerment theory-based small group discussion;   Behavioral: individual resilience counseling
13 Completed Role of HIV on Glutathione Synthesis and Oxidative Stress
Conditions: HIV Infection;   Erythrocyte Glutathione Deficiency
Interventions: Dietary Supplement: Cysteine (as n-acetylcysteine) and glycine;   Dietary Supplement: Cysteine/glycine
14 Completed A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
15 Recruiting Collection of Blood for Multiple Collaborative Studies
Condition: HIV
Intervention:
16 Completed
Has Results
Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
Condition: Human Immunodeficiency Virus Infection
Intervention:
17 Completed Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
18 Completed Drug Interactions Between Silimarine and Darunavir/Ritonavir
Condition: HIV
Intervention: Drug: Silimarine
19 Completed Antiretroviral Resistance Detection by Ultrasensitive Pyrosequencing of the HIV-1 Genome and Virological Response to Antiretroviral Rescue Treatment
Condition: HIV
Intervention:
20 Active, not recruiting
Has Results
Phase IIIB Study Evaluating the Effects of Atazanavir Powder With Ritonavir in HIV-infected Pediatric Patients
Condition: HIV
Interventions: Drug: Atazanavir Sulphate;   Drug: Ritonavir

   Previous Page Studies Shown (1-20) Next Page (21-36) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.